STOCK TITAN

BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Bio-Techne (NASDAQ: TECH) has announced a conference call and webcast scheduled for August 7, 2024, at 8:00 a.m. CDT to review their fourth quarter and fiscal 2024 financial results. Investors and interested parties can access the call via phone or webcast. For those unable to attend live, a recorded rebroadcast will be available from 11:00 a.m. CDT on August 7 until 11:00 p.m. CDT on September 7, 2024. This event provides an opportunity for stakeholders to gain insights into Bio-Techne's financial performance and future outlook.

Positive
  • None.
Negative
  • None.

MINNEAPOLIS, July 15, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, August 7, 2024, at 8:00 a.m. CDT to review fourth quarter and fiscal 2024 financial results.

Access to the discussion may be obtained as follows:

Time:     

8:00 a.m. CDT

Date:     

August 7, 2024

Dial-in:     

1-800-343-4136 or 1-203-518-9843 (for international callers)

Conference ID:     

BioTechne

Webcast:     

https://investors.bio-techne.com/ir-calendar



A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 11156560.

The replay will be available from 11:00 a.m. CDT on Wednesday, August 7, 2024, until 11:00 p.m. CDT on Saturday, September 7, 2024.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: FacebookLinkedInTwitter or YouTube.

Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com 
612-656-4416  

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-august-7-2024-to-announce-fourth-quarter-and-fiscal-2024-financial-results-302196342.html

SOURCE Bio-Techne Corporation

FAQ

When will Bio-Techne (TECH) release its Q4 and fiscal 2024 financial results?

Bio-Techne (TECH) will release its Q4 and fiscal 2024 financial results on August 7, 2024, during a conference call and webcast scheduled for 8:00 a.m. CDT.

How can investors access Bio-Techne's (TECH) Q4 2024 earnings call?

Investors can access Bio-Techne's (TECH) Q4 2024 earnings call by dialing 1-800-343-4136 (or 1-203-518-9843 for international callers) or via webcast at https://investors.bio-techne.com/ir-calendar on August 7, 2024, at 8:00 a.m. CDT.

What is the replay information for Bio-Techne's (TECH) Q4 2024 earnings call?

A replay of Bio-Techne's (TECH) Q4 2024 earnings call will be available from August 7, 2024, at 11:00 a.m. CDT until September 7, 2024, at 11:00 p.m. CDT. To access the replay, dial 1-844-512-2921 (or 1-412-317-6671 for international callers) and use Conference ID 11156560.

Bio-Techne Corp.

NASDAQ:TECH

TECH Rankings

TECH Latest News

TECH Stock Data

11.34B
157.24M
1.04%
99.48%
2.22%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
MINNEAPOLIS